面对复杂多变、基建迥异的海外环境，中国企业化海外挑战为市场机遇，实现国际化增长突破的同时， 从 "全球化参与者" 转向 "全球化规则贡献者" 。 EDGE AWARDS创新评选始终以"潜在价值"为核心，着眼于世界前沿科技，是具有权威性、先锋性和敏 锐挖掘力的全球创新榜单。多年来，EDGE AWARDS创新榜单记录了许多扬帆出海入局全球市场的先 锋企业。今年，新一批出海探索者又创作出全球化的新篇章。2025 年 EDGE AWARDS 全球创新评选 ——"年度全球化公司榜" 现已荣耀揭榜，以下是完整获奖名单： 全球化先锋企业 该榜单颁发给在2025年波动的国际形势下，仍坚定出海、并在海外市场取得突破性成绩、收获客户信 任、市场优良反馈、以及高营收的中国企业和品牌。他们既可以是新型消费类公司和科技企业，也囊括 提供数字化产品和服务的中国企业。 ECARX 2025年，在海外政策充满变动的情况下，中国企业从跨境走向深入本地化，从出海加速走向全球化。 今年年初以来，美国政府相继颁布"取消800美金以下跨境小包免税"、"对等关税"等政策，欧盟推出 《新电池法》、"取消跨境小包免税"政策。在多项国际政策变动之下，中国企业 ...

Core Insights - The Chinese medical equipment industry is advancing rapidly during the 14th Five-Year Plan period, integrating cutting-edge technologies like AI and 5G to create an innovative industrial ecosystem, contributing significantly to the "Healthy China" initiative and enhancing global competitiveness in medical equipment manufacturing [1][4]. Group 1: Technological Breakthroughs - Domestic high-end ultrasound systems are achieving unprecedented image resolution, enabling the detection of micro-level structures for more accurate early disease diagnosis [2]. - The introduction of ultra-weak magnetic imaging devices allows for efficient medical examinations without noise or the need for contrast agents, providing patients with comprehensive reports in under three minutes [2]. - Major advancements include ECMO machines, laparoscopic surgical robots, photon counting spectral CT, and high-performance PET/CT systems, showcasing significant technological achievements in the medical equipment sector [2]. Group 2: Innovation and R&D Investment - Companies are transitioning from being "followers" of international technology to "leaders" with independent innovation capabilities, supported by substantial R&D investments, with firms like Mindray allocating approximately 10% of their revenue to R&D annually [3]. - The number of medical equipment enterprises in China reached 33,400 during the 14th Five-Year Plan, with over 4,000 large-scale companies and around 160 listed firms, indicating a robust growth in the sector [3]. Group 3: New Dynamics in Medical Equipment - The integration of AI with medical imaging devices enhances efficiency by automating patient positioning and reducing unnecessary radiation exposure [4]. - The use of 5G technology in surgical robots enables remote surgeries, allowing doctors to collaborate across vast distances, thus improving access to high-quality medical services [4]. - The market size of China's medical equipment industry surpassed 1 trillion yuan during the 14th Five-Year Plan, fostering the development of six national advanced manufacturing industry clusters [4]. Group 4: Ecosystem Development - Innovative models for medical equipment development are emerging, such as Beijing's innovation center for surgical robots and Chongqing's collaborative approach between enterprises and research institutions [5]. - Shenzhen has established a 4 billion yuan fund for high-end medical equipment, facilitating rapid growth and global expansion for domestic companies [5]. - A comprehensive innovation ecosystem is being developed, supported by national and local initiatives, to enhance the medical equipment sector's growth potential [6].

Core Viewpoint - The approval of ultrasound products by United Imaging Healthcare (联影医疗) for NMPA registration enhances the company's medical imaging product matrix and is expected to drive new revenue growth opportunities [1] Company Summary - The newly approved ultrasound products cover a full range of categories including ultra-high-end, high-end, mid-range, and economical models, applicable in various departments such as cardiology, obstetrics, and emergency care [1] - The company is anticipated to see significant revenue growth in Q4, supported by a high level of industry bidding activity and the recognition of domestic orders from the first three quarters [1] - The introduction of high-end products like 5.0T MR, uMI Panorama, and photon-counting spectral CT is expected to contribute to steady revenue and net profit growth in the coming year [1] Industry Summary - The medical imaging industry is projected to maintain a favorable outlook due to ongoing equipment upgrade projects and strong growth in overseas markets [1] - The overall profit margin for the company is expected to improve significantly throughout 2025, driven by the anticipated performance in Q4 and beyond [1]

新华财经上海11月26日电（记者李荣）持续强化平台能级、优化要素配置、完善产业生态，建设长三角 地区具有影响力和竞争力的生物医药创新高地与产业标杆。记者26日从2025年嘉定生物医药产业发展大 会暨中国高端医疗产业集群创新合作论坛上获悉，上海嘉定正加快高端医疗器械产业集聚区建设。 上海已出台促进高端医疗器械产业全链条发展行动方案，提出要加快建设产业集聚区，支持相关创新型 企业做大做强，推动沪产创新器械走向全球。嘉定作为上海发展高端医疗器械的三大集聚区之一，将进 一步集聚各类资源要素，加快推动高端医疗器械产业创新发展。 嘉定不仅拥有瑞金医院国家医学中心、复旦大学国际科技创新中心等顶级创新资源，更集聚了联影医疗 这样的行业龙头。正在打造的"上海械谷"和"联影小镇"，一个专注"器械"，一个聚焦高端医疗设备，形 成了优势互补、协同发展的格局。 据相关方案，目标是到2027年，将嘉定打造成为具有国际竞争力的高端医疗器械产业集聚区。具体体现 在三个维度。 ——在创新维度上，实现"双新增"：新增首次获批境内第三类医疗器械注册证超100件，在海外市场获 批医疗器械产品超30件；新增2至3家医疗器械技术创新中心、概念验证中心、 ...

Group 1 - The China International Import Expo (CIIE) has expanded significantly since its inception in 2018, with total exhibition area increasing from 270,000 square meters to 430,000 square meters, a growth of over 55% [1] - CIIE has attracted a cumulative total of 23,000 foreign exhibitors and has generated an intended transaction value exceeding $500 billion, showcasing approximately 3,000 new products, technologies, and services across various sectors including healthcare, automotive, and green technology [1] - The event has seen participation from 31 countries as guest countries and over 180 countries and regions, including 151 countries involved in the Belt and Road Initiative, with more than 1,200 supporting activities held [1] Group 2 - Shanghai has emerged as a global innovation hub in the biopharmaceutical industry, with 8 Class I innovative drugs and 7 Class III innovative medical devices approved for market this year, alongside 4 Shanghai-produced drugs entering major international markets [3] - The city has established 11 major scientific infrastructure projects, with 4 under construction and 5 planned, amounting to a total investment of approximately 35 billion yuan [5] - Shanghai scientists published 138 papers in top international journals such as Cell, Nature, and Science from January to September this year, accounting for 30.1% of the national total, while R&D expenditure as a percentage of GDP increased from 3.4% to around 4.4% over the past decade [5]

Core Insights - The Chinese nuclear technology application industry has made significant progress, with the industry scale reaching new heights and achieving breakthroughs in high-quality development [1] Industry Overview - The output value of China's nuclear technology application is projected to reach 890 billion yuan in 2024, accounting for 0.66% of GDP, which is a 27% increase from 2022 [1] - The compound annual growth rate from 2020 to 2024 is estimated at 15.6% [1] - The distribution of application sectors includes industrial applications (42.7%), nuclear medicine (21.7%), agricultural applications (13.9%), and foundational industries (10.3%) [1] Workforce and Infrastructure - By the end of 2024, there will be approximately 140,000 legal entities engaged in radioactive isotope/radiation device operations, employing around 960,000 people, representing growth of 34% and 17% respectively since 2022 [1] - The number of radiation devices in use is about 320,000 units, with 172,000 radioactive sources, marking increases of 17% and 4.9% respectively since 2022 [1] - There are 42 national large-scale scientific facilities related to nuclear technology, with 18 operational research reactors, including 5 capable of isotope production [1] Technological Advancements - The industry has seen rapid development in irradiation processing and nuclear medical applications, with growth rates exceeding double digits [2] - The production value of nuclear agricultural applications has surpassed 100 billion yuan, and the market penetration of various nuclear analysis and instrumentation products continues to rise [2] - Significant advancements include the approval of the world's first phased array CT and the domestic first photon counting spectral CT, among other innovations [3] International Collaboration - China has opened 12 top nuclear research facilities to the international community and established 8 IAEA collaboration centers [3] - Equipment for Thailand's micro-reactor project has been shipped, and there is a growing trend in the export of high-end nuclear medical devices and industrial irradiation equipment [3]

Group 1: Technological Innovation in Private Enterprises - Private enterprises are becoming the backbone in breaking technological bottlenecks and driving innovation, particularly in key technology sectors [1] - The development of fiber optic preform technology has enabled the production of ultra-thin fibers that support high-speed internet communication, significantly reducing data transmission times [4][6] - Jiangsu Hengtong Marine Technology Co., Ltd. has laid over 110,000 kilometers of submarine cables, facilitating global connectivity for billions of people [10] Group 2: Advancements in Medical Technology - Domestic PET/CT technology has improved diagnostic efficiency, reducing scan times from 20-30 minutes to just 1-3 minutes, while increasing sensitivity by 40 times [15][17] - The approval of the photon counting spectral CT by United Imaging Healthcare enhances imaging resolution and aids in early detection of diseases [17][21] - Chinese medical device companies are expanding globally, with products now available in over 80 countries, contributing to the global healthcare sector [21] Group 3: Robotics and AI Integration - Robotics is becoming a key driver for industrial upgrading and innovation in China, with applications expanding across various sectors including logistics and healthcare [22] - The integration of multiple intelligences in robotics, such as operational, interactive, and motion intelligence, is enhancing their functionality and adaptability in everyday tasks [26] - The rapid development and deployment of humanoid robots indicate a significant acceleration in the robotics sector, with future advancements expected to improve their sensory and cognitive capabilities [28]

Group 1: Technological Innovation and Industry Impact - Private enterprises are becoming the backbone in breaking technological bottlenecks and driving innovation in key technology fields [1] - The development of "hollow-core fiber" technology provides unlimited space for the massive data demands of AI and IoT, addressing the limitations of traditional optical fibers [7][9] - The company has laid over 110,000 kilometers of submarine cables globally, facilitating communication for billions of people and supporting national strategies like "Broadband China" and "5G + Dual Gigabit Network" [10] Group 2: Medical Technology Advancements - The domestic PET/CT technology has significantly reduced scanning time from 20-30 minutes to just 1-3 minutes, enhancing diagnostic efficiency [13] - The sensitivity of PET imaging has improved by 40 times compared to other devices, allowing for better detection of diseases [13] - Chinese medical equipment companies, such as United Imaging, have expanded globally, serving over 15,300 medical institutions in more than 80 countries [16] Group 3: Robotics and Automation - The past year has seen rapid advancements in humanoid robots, with improvements in their sensory capabilities to operate effectively in complex environments [18] - Data collection and training processes for robots are generating 30,000 to 50,000 real data points daily, enhancing their operational efficiency [19] - Humanoid robots are becoming key drivers of new productive forces, integrating into various application fields such as industrial production and healthcare [19]

Group 1: Technological Innovation in Private Enterprises - Private enterprises are becoming the backbone in breaking technological bottlenecks and driving innovation, particularly in key technology sectors [1] - Jiangsu Hengtong Marine Technology Co., Ltd. has laid over 110,000 kilometers of submarine optical cables, enabling connectivity for billions of people globally [3] - The development of hollow-core fiber technology provides significant advantages for data transmission, including ultra-low loss and near-light-speed transmission [2] Group 2: Advancements in Medical Technology - Domestic PET/CT technology has significantly reduced scanning time from 20-30 minutes to just 1-3 minutes, enhancing patient diagnosis efficiency [4] - The sensitivity of PET imaging has improved by 40 times compared to traditional devices, allowing for better detection of tumors [4] - The launch of the photon-counting spectral CT by United Imaging Healthcare represents a breakthrough in high-resolution imaging, aiding in early disease detection [6] Group 3: Robotics and AI Development - Robotics is becoming a key driver for industrial upgrading and innovation in China, with applications expanding across various sectors [7] - The development of humanoid robots is accelerating, with advancements in their sensory capabilities to better interact with complex environments [8] - Data collection and training processes for robots are being optimized to enhance their operational intelligence and interaction skills [7]

Core Viewpoint - GE Healthcare is reportedly exploring options to sell its stake in the Chinese market due to declining revenues, rising tariff costs, and increasing competition from local companies [1][3]. Financial Performance - GE Healthcare's global revenue for the year reached $19.7 billion, a slight increase of 1% year-on-year, while the adjusted EBIT was $3.2 billion [3]. - In China, GE Healthcare's revenue for the year was $2.36 billion, representing a significant decline of 15%, marking the largest drop since the company became independent in 2023 [3]. - In comparison, Siemens Healthineers achieved revenue of €11.571 billion (approximately $13.39 billion) in the first half of 2025, a 7% increase, while GE Healthcare's revenue was $9.78 billion, a 3% increase [3]. Market Competition - Siemens Healthineers is the only major player to experience growth in the Chinese market, with a 2.4% increase in performance during the first half of 2025 [3]. - Local companies such as United Imaging, Mindray, and Neusoft are rapidly gaining market share, employing integrated strategies to challenge foreign giants [3][4]. Technological Advancements - Local companies have made significant strides in high-end medical equipment, with United Imaging and Neusoft both receiving approval for photon-counting CT devices, marking a shift from "catching up" to "leading" in next-generation CT technology [4][5]. - The global market for photon-counting CT is projected to reach approximately $2 billion by 2025, with the approval of these devices creating a dual-leader scenario in the market [5]. Strategic Implications - The approval of domestic photon-counting CT devices signifies a critical turning point for local high-end imaging equipment, moving from "replacement" to "leadership" in the market [5]. - The competitive landscape in China's medical device market is undergoing a transformation, posing unprecedented challenges for multinational corporations [5].